| P2093 | author name string | David L Cutler | |
| | Samir K Gupta | |
| | Karen Kolz | |
| P2860 | cites work | Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 |
| | Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients | Q28379555 |
| | National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002. | Q34156940 |
| | Effects of alpha-interferon on theophylline pharmacokinetics and metabolism | Q34397336 |
| | Pegylation: engineering improved pharmaceuticals for enhanced therapy | Q34782103 |
| | Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD). | Q35877908 |
| | Differential effect of IFNalpha-2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs. | Q40576941 |
| | Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy | Q43037032 |
| | Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. | Q43046887 |
| | The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity | Q43775254 |
| | Assessment of cytochrome P450 activity by a five-drug cocktail approach | Q43806811 |
| | Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C. | Q44043562 |
| | Potential drug-drug interaction between interferon alfa-2b and gemfibrozil in a patient with malignant melanoma | Q46233893 |
| | Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in | Q46565181 |
| | Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteers | Q46720498 |
| | Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. | Q50584684 |
| | Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail". | Q51373538 |
| | Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes | Q73846452 |
| | Effects of interferon-alpha on cytochrome P-450 isoforms 1A2 and 3A activities in patients with chronic hepatitis C | Q77689010 |
| | Validation of incorporating flurbiprofen into the Pittsburgh cocktail | Q80212255 |
| P433 | issue | 6 | |
| P921 | main subject | pegylated interferon | Q7160835 |
| P304 | page(s) | 591-599 | |
| P577 | publication date | 2010-12-16 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Effects of multiple-dose pegylated interferon alfa-2b on the activity of drug-metabolizing enzymes in persons with chronic hepatitis C. | |
| P478 | volume | 67 | |